Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective

References

• International Diabetes Federation. Diabetes Atlas, 3rd edn. Brussels, Belgium: IDF, 2006
   Google Scholar
• Sarol JN, Nicodemus NA, Tan KM, et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 2005;21:173-83
   PubMed Web of Science ®Google Scholar
• Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006;22:671-81
   PubMed Web of Science ®Google Scholar
• Poolsup N, Suksomboon N, Jiamsathit W. Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 2008;10:S51-66
   PubMed Web of Science ®Google Scholar
• Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1-9
   PubMed Web of Science ®Google Scholar
• Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29:1757-63
   PubMed Web of Science ®Google Scholar
• McGeoch G, Moore RA. Self-monitoring of blood glucose in type 2 diabetes: what is the evidence?. Diabetes Metab Res Rev 2007;23:423-40
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89
   PubMed Web of Science ®Google Scholar
• Blonde L, Karter AJ. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med 2005;118:20-6S
   PubMed Web of Science ®Google Scholar
• Franciosi M, Pellegrini F, De Berardis G, et al. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med 2005;22:900-6
   PubMed Web of Science ®Google Scholar
• Davis WA, Bruce DG, Davis TME. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006;29:1764-70
   PubMed Web of Science ®Google Scholar
• Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-55
   PubMed Web of Science ®Google Scholar
• Schnell O, Heinemann L. Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story?. J Diab Sci Tech 2007;1:614-16
   PubMedGoogle Scholar
• Martin S, Schneider B, Heinemann L, et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006;49:271-8
   PubMed Web of Science ®Google Scholar
• Care of diabetics 2007 (annual report), Health Statistics, DM Patients Care 2007. UZIS CR 2008; available at URL: http://www.uzis.cz/article.php?type=1&mnu_id=5100&mnu_action=select
   Google Scholar
• Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44
   PubMed Web of Science ®Google Scholar
• Fuller JH, Shipley MJ, Rose G, et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983;287:867-70
   PubMed Web of Science ®Google Scholar
• Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 2003;46(Suppl 1):M9-16
   PubMedGoogle Scholar
• Schnell O, Hummel M, Weber C. Economic and clinical aspects of diabetes regarding self-monitoring of blood glucose. Diabetes Technol Ther 2008;10:S72-81
   Web of Science ®Google Scholar
• Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-4
   PubMed Web of Science ®Google Scholar
• Derr R, Garrett E, Stacy GA, et al. Is HbA(1c) affected by glycemic instability?. Diabetes Care 2003;26:2728-33
   PubMed Web of Science ®Google Scholar
• Kolb H., Schneider B, Heinemam L, et al. Type 2 diabetes phenotype and progression is significantly different in if diagnosed before versus after 65 years of age. J Diabetes Sci Technol 2008;2:82-90
   PubMedGoogle Scholar
• Schneider B, Martin S, Heinemann L, et al. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes – results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung 2007;57:762-9
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: Royal College of Physicians, 2008
   Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes – 2009. Diabetes Care 2009;32:S13-61
   PubMed Web of Science ®Google Scholar
• IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation, 2005
   Google Scholar
• Mauskopf JA, Earnshaw S, Mullins CD. Budget impact analysis: review of the state of the art. Expert Rev Pharmacoeconom Outcome Res 2005;5:65-79
   PubMedGoogle Scholar
• Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis: Report of the ISPOR Task Force on Good Research Practices-Budget Impact Analysis. Value Health 2007;10:336-47
   PubMed Web of Science ®Google Scholar
• Brunerova L, Andel M. Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome. Vnitr Lek 2003;49:457-64
   PubMedGoogle Scholar
• VZP CR health insurance company of the Czech Republic. Císelník – PZT. Reimbursement list 2009; available at URL: http://www.vzp.cz/cms/internet/cz/Lekari/Ciselniky/
   Google Scholar